SCHEMBL770280

SCHEMBL770280

O=C(CCCC(=O)N1CCCC2CCCCC21)NCCc1cccc(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
ALDH1A1 P00352 4/20 0.52
KMT2A Q03164 3/20 0.52
F2 P00734 2/20 0.50
TAAR1 Q96RJ0 2/20 0.49
GLA P06280 1/20 0.49
HPGD P15428 3/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
PLAAT3 P53816 1/20 0.44
PLAAT5 Q96KN8 1/20 0.44
PLAAT2 Q9NWW9 1/20 0.44
PLAAT4 Q9UL19 1/20 0.44
EPHX2 P34913 1/20 0.43
DPP4 P27487 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL769854 0.88 KMT2A (0.50) SMN1; SMN2KMT2ATAAR1DPP4DPP8
SCHEMBL770835 0.88 DRD2 (0.55) ALDH1A1KMT2AHPGDMAPTDRD2
SCHEMBL770751 0.88 DPP4 (0.54) SMN1; SMN2KMT2ATAAR1MEN1NPC1
SCHEMBL770752 0.86 FKBP1A (0.48) ALDH1A1KMT2AMEN1
SCHEMBL770320 0.86 DPP4 (0.54) SMN1; SMN2KMT2ATAAR1MEN1NPC1
SCHEMBL771660 0.84 DPP4 (0.43) SMN1; SMN2ALDH1A1MAPTNPC1RAB9A
SCHEMBL769750 0.84 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1HPGDMAPTDRD2
SCHEMBL769995 0.83 EPHX2 (0.54) KMT2AMEN1NPC1RAB9AEPHX2
SCHEMBL770465 0.83 DPP4 (0.45) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL770524 0.82 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1TAAR1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 SMN1; SMN2 3653/4885ALDH1A1 144/4885KMT2A 3868/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 SMN1; SMN2 3637/4885ALDH1A1 142/4885KMT2A 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.